Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 305.95 INR 0.08% Market Closed
Market Cap: 138.6B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Relative Value

The Relative Value of one MARKSANS stock under the Base Case scenario is 179.06 INR. Compared to the current market price of 305.95 INR, Marksans Pharma Ltd is Overvalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MARKSANS Relative Value
Base Case
179.06 INR
Overvaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
32
Median 3Y
2
Median 5Y
1.7
Industry
2.6
Forward
5.1
vs History
1
vs Industry
17
Median 3Y
13.8
Median 5Y
11.9
Industry
23
Forward
35.4
vs History
1
vs Industry
11
Median 3Y
20.5
Median 5Y
17.5
Industry
17.8
vs History
vs Industry
5
Median 3Y
27.8
Median 5Y
22.4
Industry
25.4
vs History
1
vs Industry
18
Median 3Y
2.4
Median 5Y
2.5
Industry
2.2
vs History
1
vs Industry
31
Median 3Y
1.7
Median 5Y
1.5
Industry
2.8
Forward
4.9
vs History
1
vs Industry
30
Median 3Y
3.3
Median 5Y
2.8
Industry
5.4
vs History
1
vs Industry
21
Median 3Y
8.7
Median 5Y
7.5
Industry
13.7
Forward
23.8
vs History
1
vs Industry
20
Median 3Y
10.7
Median 5Y
8.9
Industry
17.2
Forward
28
vs History
1
vs Industry
12
Median 3Y
18.3
Median 5Y
15.3
Industry
16.5
vs History
1
vs Industry
1
Median 3Y
30.8
Median 5Y
21.7
Industry
19.3
vs History
1
vs Industry
18
Median 3Y
2.6
Median 5Y
2.6
Industry
2

Multiples Across Competitors

MARKSANS Competitors Multiples
Marksans Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Marksans Pharma Ltd
NSE:MARKSANS
138.6B INR 6.1 41.5 28 33.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
Marksans Pharma Ltd
NSE:MARKSANS
Average P/E: 34.3
41.5
96%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top